DrugPatentWatch Database Preview
PAROEX Drug Profile
» See Plans and Pricing
When do Paroex patents expire, and what generic alternatives are available?
Paroex is a drug marketed by Sunstar Americas and is included in one NDA.
The generic ingredient in PAROEX is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
US ANDA Litigation and Generic Entry Outlook for Paroex
A generic version of PAROEX was approved as chlorhexidine gluconate by BECTON DICKINSON on October 24th, 1989.
Summary for PAROEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 4 |
| Bulk Api Vendors: | 29 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PAROEX at DailyMed |
Recent Clinical Trials for PAROEX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Heidelberg University | Phase 4 |
| Dr. August Wolff GmbH & Co. KG Arzneimittel | Phase 4 |
| Peter Eickholz | Phase 4 |
Pharmacology for PAROEX
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for PAROEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunstar Americas | PAROEX | chlorhexidine gluconate | SOLUTION;DENTAL | 076434-001 | Nov 29, 2005 | AT | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
